2002•The LancetOpen access
Interferon beta-1a and beta-1b for treatment of multiple sclerosis
Michael Benatar
Open full text 3 citations
Abstract
This record does not include an abstract. Use the full-text link above if available.
Open-access reader
Michael Benatar
Abstract
Open-access reader
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Medicine, Interferon beta-1a, Multiple sclerosis, Interferon beta-1b, Interferon beta, Internal medicine, BETA (programming language), Clinical trial